SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001047469-14-000656
Filing Date
2014-02-06
Accepted
2014-02-06 17:01:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 10-12G/A a2218187z10-12ga.htm 10-12G/A 35904
2 EX-99.1 a2218187zex-99_1.htm EX-99.1 976467
  Complete submission text file 0001047469-14-000656.txt   1013372
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-12G/A | Act: 34 | File No.: 000-55020 | Film No.: 14580874
SIC: 2834 Pharmaceutical Preparations